journal
Journals Hepatology : Official Journal ...

Hepatology : Official Journal of the American Association for the Study of Liver Diseases

https://read.qxmd.com/read/36960800/effect-of-tenofovir-based-hiv-pre-exposure-prophylaxis-against-hbv-infection-in-men-who-have-sex-with-men
#1
JOURNAL ARTICLE
Daisuke Mizushima, Misao Takano, Takahiro Aoki, Naokatsu Ando, Haruka Uemura, Yasuaki Yanagawa, Koji Watanabe, Hiroyuki Gatanaga, Yoshimi Kikuchi, Shinichi Oka
AIMS: Men who have sex with men (MSM) are vulnerable to contracting hepatitis B virus (HBV) as a sexually transmitted infection (STI). We evaluated the incidence of HBV infection (HBI) and the prophylactic effect of tenofovir-based pre-exposure prophylaxis (PrEP) on HBI in an MSM cohort. METHODS: MSM who were older than 16 years were enrolled from January 2018 and followed up until June 2021 and tested for HIV, bacterial STIs, and hepatitis B surface antigen (HBsAg)/hepatitis B surface antibody (HBsAb) and hepatitis B core antibody (HBcAb) every 3 months based on inclusion criteria, including HBsAg, HBcAb, HBsAb, and human immunodeficiency virus (HIV) negativity at enrollment...
March 27, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36943091/meld-3-0-for-adolescent-liver-transplant-candidates
#2
JOURNAL ARTICLE
Allison J Kwong, Ke-You Zhang, Noelle Ebel, Ajitha Mannalithara, W Ray Kim
BACKGROUND: Adolescents constitute a unique waitlist cohort that is distinct from younger children. MELD 3.0, which was developed in an adult population of liver transplant candidates, is planned to replace MELD-Na in the current liver allocation system for both adult and adolescents aged 12-17. We evaluated the predictive performance of MELD-Na, MELD 3.0, and PELD, for 90-day waitlist mortality risk among adolescent liver transplant registrants. METHODS: New waitlist registrations for primary liver transplant among individuals aged 12-17 and aged 18-25 for comparison were identified using OPTN data from Nov 17 2004 to Dec 31 2021...
March 22, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36943063/sepsis-induced-endothelial-dysfunction-drives-acute-on-chronic-liver-failure-via-angiopoietin-2-hgf-c-ebp%C3%AE-pathway
#3
JOURNAL ARTICLE
Grant Elias, Michael Schonfeld, Sara Saleh, Mark Parrish, Marina Barmanova, Steven A Weinman, Irina Tikhanovich
BACKGROUND AND AIMS: Acute-on-chronic liver failure (ACLF) is an acute liver and multisystem failure in patients with previously stable cirrhosis. A common cause of ACLF is sepsis secondary to bacterial infection. Sepsis-associated ACLF involves a loss of differentiated liver function in the absence of direct liver injury, and its mechanism is unknown. We aimed to study the mechanism of sepsis associated ACLF using a novel mouse model. APPROACH AND RESULTS: Sepsis-associated ACLF was induced by cecal ligation and puncture procedure (CLP) in mice treated with thioacetamide (TAA)...
March 22, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36939197/parathyroid-hormone-receptor-1-signaling-aggravates-hepatic-fibrosis-through-upregulating-camp-response-element-binding-protein-like-2
#4
JOURNAL ARTICLE
Ting Hong, Xuelian Xiong, Yaqiong Chen, Qiuyu Wang, Xiao Fu, Qingnan Meng, Yan Lu, Xiaoying Li
BACKGROUND AIMS: Parathyroid hormone receptor-1 (PTH1R) is a class B G protein-coupled receptor central to skeletal development, bone turnover, and calcium homeostasis. However, the role of PTH1R signaling in liver fibrosis is largely unknown. Here, the role of PTH1R signaling in the activation of hepatic stellate cells (HSCs) and hepatic fibrosis was examined. APPROACH RESULTS: PTH1R was highly expressed in activated HSCs and fibrotic liver by using human liver specimens or carbon tetrachloride (CCl4)-treated or methionine and choline-deficient diet (MCD)-fed C57/BL6 mice...
March 21, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36938877/emerging-targets-for-therapy-in-ald-lessons-from-nash
#5
JOURNAL ARTICLE
Ashwani K Singal, Vijay H Shah, Harmeet Malhi
Alcohol-associated liver disease due to harmful alcohol use and non-alcoholic fatty liver disease associated with metabolic syndrome are the two most common liver diseases worldwide. Control of respective risk factors is the cornerstone in the long-term management of these diseases. Furthermore, there are no effective therapies. Both diseases are characterized by metabolic derangements, thus, the focus of this review is to broaden our understanding of metabolic targets investigated in non-alcoholic fatty liver disease, and how these can be applied to alcohol-associated liver disease...
March 21, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36938876/preventing-two-viral-infections-with-one-tablet
#6
JOURNAL ARTICLE
Yi-Chia Huang, Chien-Ching Hung
No abstract text is available yet for this article.
March 21, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36932718/reply-the-associations-between-hepatic-steatosis-and-incident-cardiovascular-disease-and-all-cause-mortality
#7
JOURNAL ARTICLE
Heidi S Ahmed, Michelle T Long
No abstract text is available yet for this article.
March 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36932712/letter-to-the-editor-the-associations-between-hepatic-steatosis-and-incident-cardiovascular-disease-and-all-cause-mortality
#8
JOURNAL ARTICLE
Zheyu Li, Liting Zhang, Junfeng Li
No abstract text is available yet for this article.
March 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36932706/letter-to-the-editor-hepatic-interferon-regulatory-factor-8-expression-suppresses-hepatocellular-carcinoma-progression-and-enhances-the-response-to-anti-programmed-cell-death-protein-1-therapy
#9
JOURNAL ARTICLE
Wei Zhang, Ming-Kao Wang, Dan Yao, Hai-Jian Zhao, Xiao-Yu Zhang
No abstract text is available yet for this article.
March 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36929950/reply-hepatic-steatosis-and-glycemic-burden-in-chronic-hepatitis-b
#10
JOURNAL ARTICLE
Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
No abstract text is available yet for this article.
March 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36929826/letter-to-editor-association-between-birth-weight-preterm-birth-and-nonalcoholic-fatty-liver-disease-in-a-community-based-cohort
#11
JOURNAL ARTICLE
Rabia Irfan, Satesh Kumar
No abstract text is available yet for this article.
March 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36929778/letter-to-the-editor-hepatic-steatosis-and-glycemic-burden-in-chronic-hepatitis-b
#12
JOURNAL ARTICLE
Shang-Chin Huang, Jia-Horng Kao
No abstract text is available yet for this article.
March 20, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36924031/noninvasive-assessment-of-liver-disease-severity-in-patients-with-nonalcoholic-fatty-liver-disease-nafld-and-type-2-diabetes
#13
JOURNAL ARTICLE
Grazia Pennisi, Marco Enea, Vincenzo Falco, Guruprasad P Aithal, Naaventhan Palaniyappan, Yusuf Yilmaz, Jerome Boursier, Christophe Cassinotto, Victor de Lédinghen, Wah Kheong Chan, Sanjiv Mahadeva, Peter Eddowes, Philip Newsome, Thomas Karlas, Johannes Wiegand, Vincent Wai-Sun Wong, Jörn M Schattenberg, Christian Labenz, Won Kim, Myoung Seok Lee, Monica Lupsor-Platon, Jeremy F L Cobbold, Jian-Gao Fan, Feng Shen, Katharina Staufer, Michael Trauner, Rudolf Stauber, Atsushi Nakajima, Masato Yoneda, Elisabetta Bugianesi, Ramy Younes, Silvia Gaia, Ming-Hua Zheng, Calogero Cammà, Quentin M Anstee, Ferenc Emil Mózes, Michael Pavlides, Salvatore Petta
BACKGROUND: We evaluated the diagnostic accuracy of simple non-invasive tests(NITs) in NAFLD patients with type 2 diabetes(T2D). METHODS: This was an individual patient data meta-analysis of 1780 patients with biopsy-proven NAFLD and T2D. The index tests of interest were FIB-4, NAFLD Fibrosis Score(NFS), APRI, liver stiffness measurement(LSM) by vibration-controlled transient elastography(VCTE) and AGILE 3+. The target conditions were advanced fibrosis, nonalcoholic steatohepatitis(NASH) and fibrotic NASH(NASH plus F2-F4 fibrosis)...
March 17, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36915267/the-international-quest-for-the-imaging-diagnosis-of-liver-cancer
#14
JOURNAL ARTICLE
Jeong Min Lee, Ijin Joo
No abstract text is available yet for this article.
March 15, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36897269/quantifying-the-benefit-of-non-selective-beta-blockers-in-the-prevention-of-hepatic-decompensation-a-bayesian-re-analysis-of-the-predesci-trial
#15
JOURNAL ARTICLE
Ian A Rowe, Càndid Villanueva, Jessica E Shearer, Ferran Torres, Agustín Albillos, Joan Genescà, Joan C Garcia-Pagan, Dhiraj Tripathi, Peter C Hayes, Jaume Bosch, Juan G Abraldes
BACKGROUND AND AIMS: Beta-blockers have been studied for the prevention of variceal bleeding and, more recently, for the prevention of all cause decompensation. Some uncertainties regarding the benefit of beta-blockers for the prevention of decompensation remain. Bayesian analyses enhance the interpretation of trials. The purpose of this study was to provide clinically meaningful estimates of both the probability and magnitude of benefit with beta-blocker treatment across a range of patient types...
March 13, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36896975/screening-of-liver-cancer-with-abbreviated-magnetic-resonance-imaging
#16
JOURNAL ARTICLE
Maxime Ronot, Pierre Nahon, Jordi Rimola
Current recommendations for the surveillance of hepatocellular carcinoma are based on semiannual liver ultrasound (with or without serum alpha fetoprotein) in patients with cirrhosis and in subgroups with chronic hepatitis B infection. However, the sensitivity of this strategy is suboptimal for the detection of early-stage tumors especially in obese patients, due to inter-operator variability, and poor adherence. The detection rate of focal liver lesions is excellent with Magnetic Resonance Imaging (MRI), making it the best alternative candidate for surveillance...
March 13, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36896974/differential-response-of-hbv-envelope-specific-cd4-t-cells-is-related-to-hbsag-loss-after-stopping-nucleos-t-ide-analogue-therapy
#17
JOURNAL ARTICLE
Yongyin Li, Chunhua Wen, Shuqin Gu, Weibin Wang, Ling Guo, Libo Tang, Chris Kafai Li, Xuan Yi, Yang Zhou, Zheyu Dong, Xin Fu, Shihong Zhong, Yuhao Wang, Kuiyuan Huang, Junhua Yin, Chunxiu Zhong, Xieer Liang, Rong Fan, Haitao Chen, Deke Jiang, Xiaoyong Zhang, Jian Sun, Jie Peng, Jinlin Hou
BACKGROUND AND AIMS: Long-term maintenance of viral control, even HBsAg loss, remains a challenge for chronic hepatitis B (CHB) patients undergoing nucleos(t)ide analogue (NA) discontinuation. This study aimed to investigate the relationship between HBV-specific T cell responses targeting peptides spanning the whole proteome and clinical outcomes in CHB patients after NA discontinuation. APPROACH AND RESULTS: Eighty-eight CHB patients undergoing NA discontinuation were classified as responders (remained relapse-free up to 96 wk) or relapsers (relapsed patients who underwent NA re-treatment for up to 48 weeks and re-achieved stable viral control)...
March 13, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36896969/reply-portal-hypertension-and-variceal-bleeding-in-patients-with-liver-cancer-evidence-gaps-for-prevention-and-management
#18
JOURNAL ARTICLE
Manon Allaire, Dominique Thabut
No abstract text is available yet for this article.
March 13, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36896966/hbv-with-precore-and-basal-core-promoter-mutations-exhibits-a-high-replication-phenotype-and-causes-er-stress-mediated-cell-death-in-humanized-liver-chimeric-mice
#19
JOURNAL ARTICLE
Takuro Uchida, Michio Imamura, C Nelson Hayes, Yosuke Suehiro, Yuji Teraoka, Kazuki Ohya, Hiroshi Aikata, Hiromi Abe-Chayama, Yuji Ishida, Chise Tateno, Yuichi Hara, Keisuke Hino, Toru Okamoto, Yoshiharu Matsuura, Hideki Aizaki, Kenjiro Wake, Michinori Kohara, T Jake Liang, Shiro Oka, Kazuaki Chayama
BACKGROUND AND AIMS: Mutations within the precore (PC) and basal core promoter (BCP) regions of the HBV genome are associated with fulminant hepatitis and HBV reactivation. These mutations may enhance viral replication, but little is known about whether they directly induce damage to the liver. We investigated mechanisms of direct cytopathic effects induced by infection with PC/BCP mutants in the absence of immune response in vitro and in vivo. APPROACH RESULTS: Mice with humanized livers and hepatocytes derived from humanized mice were infected with either wild-type or mutant-type PC/BCP HBV, and HBV replication and human hepatocyte damage were evaluated...
March 13, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/36896961/lean-nafld-is-associated-with-adverse-liver-events-and-mortality-moving-beyond-bmi
#20
JOURNAL ARTICLE
Albert Do, Joseph K Lim
No abstract text is available yet for this article.
March 13, 2023: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
journal
journal
28566
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.